medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2009, Number 4

<< Back Next >>

Salud Mental 2009; 32 (4)

Unmet needs for treatment of alcohol and drug use in four cities in Mexico

Borges G, Medina-Mora ME, Orozco R, Fleiz C, Villatoro J, Rojas E, Zemore S

Language: English
References: 30
Page: 327-333
PDF size: 108.08 Kb.


ABSTRACT

Introduction

Even though heavy alcohol consumption is frequent, alcohol-related consequences are common, and drug use has become more common in this country, we know very little about public health response and the types of treatments available for persons with substance use disorders in Mexico. Current national estimates show that about one in every five persons with alcohol and substance use disorders received treatment in the last 12 months, but to date the rates of treatment for local communities are unknown; these data are needed for policy planning at community level. This study presents data on the treatment for substance use and substance use disorders in three urban areas of Northern Mexico and one state capital in Central Mexico. The Northern region is of particular interest in Mexico because of its proximity to the United States and previous evidence that alcohol and drug use is about twice as common in this region compared with other regions. The city of Queretaro provides a more appropria te comparison for the cities in Northern Mexico than a place as Mexico City, or the national means, due to its level of development, population size, and basic epidemiologic data on drug use.


REFERENCES

  1. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD et al.Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998;23:893-907.

  2. Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J et al.Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry 2008;192:368-75.

  3. WHO. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291:2581-90.

  4. Rehm J, Monteiro M. Alcohol consumption and burden of disease in the Americas: implications for alcohol policy. Rev Panam Salud Publica 2005;18:241-8.

  5. González-Pier E, Gutiérrez-Delgado C, Stevens G, Barraza-Lloréns M, Porras-Condey R et al. Priority setting for health interventions in Mexico’s System of Social Protection in Health. Lancet 2006;368:1608-18.

  6. Medina-Mora ME, Borges G, Fleiz C, Benjet C, Rojas E et al. Prevalence and correaltes of drug use disorders in Mexico. Rev Panam Salud Publica 2006;19:265-276.

  7. Bucardo J, Brouwer KC, Magis-Rodríguez C, Ramos R, Fraga M et al.Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood-borne infections. Drug Alcohol Depend 2005;79:281-293.

  8. Berenzon SG, Medina-Mora ME, Lara MA. Mental health services: twenty-five years of research. Salud Mental 2003;26:61–72.

  9. Borges G, Medina-Mora ME, Wang PS, Lara C, Berglund P et al. Treatment and adequacy of treatment of mental disorders among respondents to the Mexico National Comorbidity Survey. Am J Psychiatry 2006;163:1371-8.

  10. Medina-Mora ME. Encuesta de Consumo de Alcohol, Tabaco y Drogas,2005. Ciudad Juárez, Monterrey, Tijuana y Querétaro. México: Secretaría de Salud and Instituto Nacional de Psiquiatría; 2005; p.1-62.

  11. Medina-Mora ME, Borges G, Villatoro J. The measurement of drinking patterns and consequences in Mexico. J Subst Abuse 2000;12:183-96.

  12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: Fourth Edition; American Psychiatric Association; 1994.

  13. World Health Organization. Composite International Diagnostic Interview (version authorize core version 1.1). Geneva, Switzerland; 1993.

  14. Caetano R, Tam TW. Prevalence and correlates of DSM-IV and ICD-10 alcohol dependence: 1990 U.S. National Alcohol Survey. Alcohol Alcohol 1995;30:177-186.

  15. Caetano R, Room R. Alcohol dependence in the 1990 U.S. National Alcohol Survey: Operationalizing and comparing two nosological systems. Drug Alcohol Review 1994;13:257-267.

  16. Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997;27:93-105.

  17. Lara C, Medina-Mora ME, Borges G, Zambrano J. Social costs of mental disorders: Disability and work days lost. Salud Mental 2007;30:4-11.

  18. Research Triangle Institute. SUDAAN: Professional Software for Survey Data Analysis [computer program] 8.0.1. (ed.) Research Triangle Park, NC, USA: Research Triangle Institute; 2002.

  19. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 2000.

  20. Medina-Mora ME, Natera G, Borges G. Alcoholismo y abuso de bebidas alcohólicas, in Observatorio mexicano en tabaco, alcohol y otras drogas. México: CONADIC, Secretaría de Salud; 2002; p15-25.

  21. Medina-Mora ME, Cravioto P, Ortiz A, Kuri P, Villatoro J. Mexico: systems for the epidemiological diagnosis of drug abuse. Bull Narc 2003;55:105-109.

  22. Medina-Mora ME, Guiot ER. Demand of drugs: Mexico in the international perspective. Salud Mental 2003;26:1-11.

  23. Hendricks T. On the border. Part 3. Nogales, Sonora: Hospitals in southern Arizona hope to reduce their cost of caring for uninsured immigrants by improving hospitals across the border. San Francisco: Chronicle, vol 1, December 2005; p. A-1.

  24. Borges G, Benjet C, Medina-Mora ME, Orozco-Zavala R, Wang P. Treatment of mental disorders for adolescents in Mexico City. J Bulletin World Health Organization 2008;86:757–764.

  25. Spence R, Wallisch L, Smith S. Treatment seeking in populations in urban and rural settings on the border. Alcohol Clin Exp Res 2007;31:1002-11.

  26. Kessler RC, Berglund P, Demler O, Jin R, Koretz D et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.

  27. Zemore S, Mulia N, Yu Ye, Borges G, Greenfield TK. Gender, acculturation,and other barriers to alcohol treatment utilization among latinos in three National Alcohol Surveys. J Substance Abuse Treatment 2009 (in press).

  28. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J et al. Prevalence,service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. Psychol Med 2005;35:1773-83.

  29. Spence RT, Wallisch LS. Alcohol and drug use in rural colonias and adjacent urban areas of the Texas border. J Rural Health 2007;23(Suppl): 55-60.

  30. NIDA Principles of drug abuse treatment: A research based guide. Rockville,MD: National Institute of Drug Abuse; 1999; p.54.




2020     |     www.medigraphic.com